Federated Hermes, Inc. Provention Bio, Inc. Transaction History

Federated Hermes, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$4.52 - $10.57 $80,668 - $188,642	17,847 New	17,847 $188,000
Q1 2021 May 13, 2021	SELL	$10.12 - $19.45 $1,325 - $2,547	-131 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$11.79 - $18.94 $1,308 - $2,102	111 Added 555.0%	131 $2,000
Q3 2020 Nov 12, 2020	SELL	$10.34 - $15.2 $1,075 - $1,580	-104 Reduced 83.87%	20 $1,000
Q2 2020 Aug 13, 2020	BUY	$7.81 - $17.0 $968 - $2,108	124 New	124 $2,000
Q1 2020 May 13, 2020	SELL	$5.42 - $17.75 $569 - $1,863	-105 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.84 - $14.9 $613 - $1,564	105 New	105 $2,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.